Qule Pharma Private Limited - Company Profile

It is a pharma private limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2020.
2020 Vishakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Qule Pharma Private Limited

Qule Pharma Private Limited, a active private limited company, was established on 16 November 2020 in Vishakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304AP2020PTC116442. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Employing 22 professional, Its leadership includes Nityananda Reddy Kambam (Director), Santhanam Subramanian (Director), Rama Krishna (Director). Past directors included Sanjeev Indravadan Dani, Nityananda Reddy Kambam, Phaneemdra Prasad Gorla. It holds ₹160.00 Cr open charges and ₹210.00 Cr settled loans. Its latest AGM occurred on 01 September 2025, with the balance sheet filed on 31 March 2025. It is based at Unit 14, Jn Pharma City, Plot No 17, Rno.10, 11 & 19, 20, E Bonangi Vlg,, Vishakhapatnam, Andhra Pradesh, 531021.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24304AP2020PTC116442

  • Registration Number

    116442

  • Incorporation Date

    16 November 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 5 Year, 4 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 160.00 Cr
  • Satisfied Charges ₹ 210.00 Cr
  • Revenue Growth **** %
  • Profit Growth **** -10407.07%
  • Ebitda **** 71.63%
  • Net Worth 106003.92%
  • Total Assets **** 18.55%
Company report

Qule Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Qule Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Qule Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Nityananda Reddy Kambam Director 01 Dec 2023 Current
Santhanam Subramanian Director 16 Nov 2020 Current
Rama Krishna Director 25 Apr 2022 Current
Bala Subramanyam Sami Reddy Palle Reddy Additional Director 14 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 21 Nov 2023 Past
Pramod Abcsdd Director Appointed In Casual Vacancy 27 Dec 2023 Past
Pramod Abcsdd Director 17 Aug 2022 Past
Pramod Abcsdd Additional Director 26 Jul 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Qule Pharma.

Qule Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 10407.07% decrease in profit. The company's net worth Soared by an impressive increase of 106003.92%.

Qule Pharma revenue growth over time
Qule Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 18.55%
*******
*******
*******
*******
Profit or Loss
*******
 -10407.07%
*******
*******
*******
*******
Net Worth
*******
 106003.92%
*******
*******
*******
*******
EBITDA
*******
 71.63%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Qule Pharma?

In 2023, Qule Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹1,600,000,000.00

Satisfied Charges

₹2,100,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 160.00 Cr
Latest Charge Details
Date Lender Amount Status
16 May 2023 Others ₹160.00 Cr Open
04 Nov 2024 State Bank Of India ₹210.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Qule Pharma?

Qule Pharma has a workforce of 22 employees as of Mar 25, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Qule Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Qule Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Qule Pharma
Recent Activity within the Organization
  • Charges

    A charge registered on 04 Nov 2024 via Charge ID 101020726 with State Bank Of India was fully satisfied on 19 Jan 2026. was recorded as a recent event.

  • Charges

    A charge with Others of Rs. 1,600.00 M registered on 16 May 2023 with Charge ID 100730442 was modified on 02 Dec 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Bala Subramanyam Sami Reddy Palle Reddy was appointed as a Additional Director was appointed as a Additional Director on 14 Nov 2025 & has been associated with this company since 4 months 14 days . was documented.

  • Annual General Meeting

    Qule Pharma Private Limited last Annual general meeting of members was held on 01 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Qule Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Vijayawada. was completed.

  • Charges

    Progress on A charge with State Bank Of India amounted to Rs. 2,100.00 M with Charge ID 101020726 was registered on 04 Nov 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Qule Pharma Private Limited?

The CIN of Qule Pharma Private Limited is U24304AP2020PTC116442.

Where is Qule Pharma Private Limited headquartered?

Qule Pharma Private Limited is headquartered at Unit 14, Jn Pharma City, Plot No 17, Rno.10, 11 & 19, 20, E Bonangi Vlg,, Vishakhapatnam, Andhra Pradesh, 531021.

When was Qule Pharma Private Limited incorporated?

Qule Pharma Private Limited was incorporated on 16 November 2020.

Who are the current directors of Qule Pharma Private Limited?

The current directors of Qule Pharma Private Limited are

What is the primary industry of Qule Pharma Private Limited?

The primary industry of Qule Pharma Private Limited is Manufacturing.

Is Qule Pharma Private Limited a listed company?

Qule Pharma Private Limited is unlisted.

What is the capital structure of Qule Pharma Private Limited?

The authorized capital of Qule Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available